W.088Anthropic’s bankers are preparing to price its IPO above the $70–78 range, the FT reports, at $1.5T or more fully diluted. That implies about $83 a share, 7% above the top, and about $1.09T on shares outstanding
Anthropic’s bankers are preparing to price its IPO above the filed $70–78 range and lift the valuation to $1.5T or more, the Financial Times reported on November 11. That figure is fully diluted, according to FinanceFeeds’ account of the report. On the share count behind the earlier $1.4T headline it implies about $83.33 a share, 6.8% above the top of the range, and about $1.09T on the shares that will be outstanding. The FT said the raise could pass $100B; counting the underwriters’ option and the $26B placement, the filed terms already come to $100.0B at $78.
What the FT reported, and what has not changed
The banks are preparing to raise the price, the FT reported, citing five people familiar with the matter. Its headline says they “prepare to increase” the valuation to $1.5T or more; other outlets’ accounts of the same report say the banks are weighing a higher price or now expect one. The offering is led by Goldman Sachs and Morgan Stanley. Three backers told the FT that Anthropic is focused on raising as much as possible in the listing, according to a summary of the article. Bloomberg reported the order book was multiple times oversubscribed, Yahoo Finance said. Pricing is expected on November 18 and trading as soon as November 19, according to FinanceFeeds and Yahoo Finance.
Nothing new has been filed. The range, the 825M shares and the $26B placement are those of the November 10 amendment that W.073 set out, and Anthropic has not commented on the report, FinanceFeeds said. What changed in a day is the direction: W.073 found the range valued the shares outstanding at $917B to $1.02T, little different from May’s $965B round.
$1.5T fully diluted is about $1.09T on shares outstanding
Anthropic’s value at four IPO prices on two bases, $ trillions. Strong grey: shares outstanding after the offering and placement, from the filing’s count. Grey: fully diluted, using the roughly 18.0B shares implied by the $1.404T that TechCrunch reported at $78. Dashed bars are the price implied by the FT’s $1.5T, about $83.33; the FT said “or more”, so they are a floor for its report. The faint grey bar is May’s post-money valuation, $965B.
Valuation and proceeds by price
| Price | Shares outstanding | Fully diluted | Offering | Option | With placement |
|---|---|---|---|---|---|
| $70.00 | $0.917T | $1.260T | $57.75B | $8.66B | $92.41B |
| $74.00 | $0.968T | $1.332T | $61.05B | $9.16B | $96.21B |
| $78.00 | $1.019T | $1.404T | $64.35B | $9.65B | $100.00B |
| ~$83.33 | $1.087T | $1.500T | $68.75B | $10.31B | $105.06B |
Offering is 825M shares, including 23.65M from selling holders whose proceeds do not go to Anthropic. Option is 123.75M more shares from Anthropic if exercised in full. “With placement” adds the $26B.
The two numbers in the headline
$1.5T is a fully diluted figure. FinanceFeeds’ account says so, and puts the filed range at $1.26T to $1.41T on the same basis. The filing gives no fully diluted count; the $1.404T reported at $78 implies about 18.0B shares, which FinanceFeeds describes as counting options, stock units and convertibles. On that count $1.5T is about $83.33 a share. The shares outstanding after the offering would be worth about $1.09T at that price, against $1.02T at $78. For the shares outstanding alone to be worth $1.5T, the price would have to be about $115.74.
The $100B depends on what is counted. At $78 the 825M shares raise $64.35B, the underwriters’ option $9.65B more if exercised in full, and the placement $26B: $100.00B together. Any price above $78 therefore passes $100B on that count. BeInCrypto reaches roughly $100B the same way; the summaries we read do not say how the FT counted. Without the option the price would have to reach $89.70. Counting only money that goes to Anthropic, leaving out the selling holders’ shares, it passes $100B at $79.99 with the option and $92.34 without. At about $83.33, Anthropic’s own new shares and the placement would bring in $92.8B before the option, and $103.1B with it.
With the option and the placement, the raise is $100.0B at $78 and $105.1B at about $83.33
Gross proceeds by component, $ billions: new shares sold by Anthropic (strong grey), selling holders’ shares (black), the underwriters’ option if exercised in full (dashed), and the $26B placement of nonvoting stock with seven suppliers at the IPO price (grey). SpaceX’s June IPO is shown for scale, with its over-allotment outlined; the $86.2B total is the figure W.064 used, and Reuters reported $85.7B. The dashed line marks $100B.
Whether the raise passes $100B at about $83.33 depends on the option
The share price at which the raise passes $100B under four ways of counting it, shown as a premium to the $78 top of the range. The dashed bar is the price implied by $1.5T fully diluted, 6.8% above $78, for comparison. Counts with the option pass $100B below that price; counts without it do not.
Multiples and precedent
At $1.5T fully diluted, Anthropic would be valued at about 22.1× its third-quarter revenue annualized. Third-quarter revenue was $16,956M, about $67.8B at a yearly rate. The multiple is 20.7× at the top of the filed range, and 16.0× on shares outstanding at about $83.33.
A price a little above the range would not by itself need a new range. Price and size changes can be made in the final prospectus when together they change the registered maximum offering amount by no more than 20%, according to a Latham & Watkins guide; about $83.33 is 6.8% above $78. IPOs priced above their range have averaged a first-day gain of 50%, against 12% for those priced within it and 3% below, in Jay Ritter’s data on US offerings since 1980 as cited by Yahoo Finance.
What this changes on inthesingularity.ai
- W.073 stands as the record of the filed terms. If an amended range or a final price is filed, the valuation on shares outstanding and the proceeds here should be recomputed from it; every figure above scales with price.
- Anthropic’s S-1 and the labs funding pack: no figure to take yet. The lead is the final price and whether the option is exercised. At $78, Anthropic’s $64.4B offering is below SpaceX’s $75.0B base deal, and at about $83.33 it would still be, at $68.8B; with the option in full it would be $79.1B, against SpaceX’s $86.2B with its over-allotment. The offering alone passes SpaceX’s base deal at about $90.91 a share.
Sources and method
| Item | Figure | Source |
|---|---|---|
| FT report | Bankers preparing to increase the valuation to $1.5T or more, which could push the funds raised past $100B; backers say the focus is raising as much as possible | Financial Times, Nov 11, via Edward Conard’s macro roundup |
| FT report | Five people familiar; $1.5T or more is fully diluted; the filed range is $1.26T–1.41T on that basis; Goldman Sachs and Morgan Stanley lead; Anthropic has not commented; pricing Nov 18, trading Nov 19 | FinanceFeeds, Nov 11 |
| Count behind $100B | BeInCrypto’s own sum: up to $64B of shares, an option of almost $10B and the $26B placement, roughly $100B | BeInCrypto, via Yahoo Finance, Nov 11 |
| Demand, history | Bankers now expect to price above the range; Bloomberg reported the book multiple times oversubscribed; Ritter: IPOs priced above range averaged a 50% first-day gain, 12% within, 3% below | Yahoo Finance, Nov 11 |
| Prospectus | Range $70.00–78.00; 825M Class A shares, 801.35M from Anthropic and 23.65M from selling holders; option 123.75M; $26B placement at the IPO price; 13.087B shares of all classes outstanding at $74, including 351.35M placement shares | Anthropic, S-1/A No. 2, Nov 10 |
| Fully diluted | $1.404T at the top of the range, fully diluted | TechCrunch, Nov 10 |
| Revenue | Third-quarter revenue $16,956M | Anthropic, S-1/A No. 1, Nov 2 |
| Series H | $65B at $965B post-money | Anthropic, May 28 |
| SpaceX | $75.0B base deal; $86.2B with the over-allotment | Renaissance Capital, Jun 2026, as in W.064 |
| Pricing rules | Price and size changes can go in the final prospectus if together they change the registered maximum offering amount by no more than 20% | Latham & Watkins, on upsizing or downsizing an IPO |
We did not read the FT article; its contents are taken from the summaries listed, which differ on whether the banks are preparing to, weighing or expecting to price above the range. Fully diluted count: $1,404B ÷ $78 = 18.00B shares; the filing states none. Implied price: $1,500B ÷ 18.00B = $83.33; ÷ 78 − 1 = 6.8%; ÷ 74 − 1 = 12.6%. Shares outstanding: 13,086,672,593 − 351,351,348 = 12,735,321,245 before placement shares; value at price p = that count × p + $26B, since the placement buys $26B of stock at p. At $83.33: $1087.3B; at $78: $1019.4B. Shares outstanding worth $1.5T: ($1,500B − $26B) ÷ 12.7353B = $115.74. Raise at $78: 825M × 78 = $64.35B; 123.75M × 78 = $9.6525B; + 26 = $100.0025B. At $83.33: $68.75B + $10.31B + 26 = $105.06B. Thresholds: ($100B − $26B) ÷ shares: 948.75M → $78.00; 925.10M → $79.99; 825.00M → $89.70; 801.35M → $92.34. SpaceX: $75.0B ÷ 825M shares = $90.91; offering plus option at $83.33 = $79.06B. Multiples: 16.956 × 4 = 67.82; 1,500 ÷ 67.82 = 22.1; 1,404 ÷ 67.82 = 20.7; 1087 ÷ 67.82 = 16.0. The implied price moves with the fully diluted count, which is inferred; a different count would give a different price.
Wire reports are written within hours of the news, on a six-hour schedule. Each lists its sources and shows the arithmetic behind its figures. Not investment advice.